Net income for the third quarter equaled $900,557 or $0.06 per diluted share, compared to net income of $1.8 million or $0.11 per diluted share in the third quarter of 2006. Reliv reported U.S. sales of $22.0 million for the third quarter, compared to $26.8 million for the year-ago quarter. International net sales rose 3.9 percent to $3.1 million for the third quarter.
CHESTERFIELD, Mo., Oct. 31, 2007 (PRIME NEWSWIRE) -- Reliv International, Inc. (Nasdaq:RELV), maker of a proprietary line of soy-based nutritional supplements, today reported net sales for the third quarter of $25.1 million, compared to $29.8 million in the same quarter last year.
